Finance

Lists
Why is SKNY down 7.69%?
Dive Deeper
SKNY:CNSX
LIR Life Sciences Corp
CA$0.12
-7.69%
(-0.0100) 1D
Oct 27, 9:30:00 AM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for SKNY...
Open
CA$0.12
High
CA$0.12
Low
CA$0.12
Mkt. cap
3.44M
Avg. vol.
13.70K
Volume
1.50K
52-wk high
CA$2.41
52-wk low
CA$0.10
EPS
-CA$0.18
Open
CA$0.12
High
CA$0.12
Low
CA$0.12
Mkt. cap
3.44M
Avg. vol.
13.70K
Volume
1.50K
52-wk high
CA$2.41
52-wk low
CA$0.10
EPS
-CA$0.18
News stories
From web sources and news partners
About LIR Life Sciences Corp
CEO-
Employees-
Founded2018
HeadquartersVancouver, British Columbia, Canada
SectorPharmaceutical industry
Websiteblackbirdmetals.ca
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Oct 2025
Jan 2026
Apr 2026
Jul 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
6.67K
5.00K
Cost of revenue
-
-
6.67K
5.00K
Research and development expenses
-
10.00K
52.10K
255.17K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
61.85K
1.13M
317.32K
323.37K
Operating expense
67.88K
1.87M
1.23M
981.44K
Total operating expenses
67.88K
1.87M
1.24M
986.44K
Operating income
-67.88K
-1.87M
-1.24M
-986.44K
Other non operating income
-6.52K
-343.44K
-57.71K
-3.70K
EBT including unusual items
-64.24K
-2.16M
-1.40M
-989.04K
EBT excluding unusual items
-196.00K
-2.21M
-1.30M
-989.04K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-64.24K
-2.16M
-1.40M
-989.04K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
142.00
-
-
20.00
Interest expense
-
-
-
-
Net interest expenses
10.69K
-
-
20.00
Depreciation and amortization charges
-
-
1.28K
-
EBITDA
-64.40K
-1.87M
-1.24M
-985.20K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps